Why Lumen’s governance changes matter for shareholders

Lumen Technologies (LUMN) has put corporate governance in the spotlight ahead of its May 20, 2026 annual meeting, asking investors to approve amendments removing supermajority voting on several key charter and bylaw provisions.

At the same time, the company is urging investors to vote against a shareholder proposal that would require any poison pill to be put to a shareholder vote within a year, setting up a clear choice on how much direct influence investors want over future defenses.

These governance moves come after a sharp swing in investor sentiment, with Lumen’s share price at US$7.44 and a 12.05% 1 month share price return alongside a very large 3 year total shareholder return, even though the 5 year total shareholder return remains negative.

If you are weighing how governance debates might reshape other corners of the market, this can be a useful moment to scan 36 AI infrastructure stocks

With Lumen’s shares at US$7.44, a value score of 2, recent 1 year and 3 year total returns in very large positive territory but a 5 year total return still negative, are you looking at mispricing, or at a market that is already factoring in future growth?

Most Popular Narrative: 3.1% Undervalued

The most followed narrative puts Lumen’s fair value at $7.68, just above the last close at $7.44, framing the recent governance moves against a tight valuation gap.

Lumen's large pipeline of AI-driven network infrastructure and Platform Connectivity Fiber (PCF) contracts, particularly with hyperscalers and data center providers, positions the company to capture long-duration, higher-margin recurring revenues from explosive data growth, benefiting long-term revenue and margin expansion.

Read the complete narrative. Read the complete narrative.

Curious what sits behind that fair value call? The narrative leans heavily on shifting revenue mix, margin rebuild, and a future profit multiple that is not typical for a company still loss making today. The exact assumptions might surprise you.

Result: Fair Value of $7.68 (UNDERVALUED)

However, the story could change quickly if legacy revenue declines remain in double digits or if large hyperscaler customers pull back, which could put fresh pressure on margins.

Another View: Cash Flows Paint A Harsher Picture

While the popular narrative suggests Lumen is about 3.1% undervalued at a fair value of $7.68, our DCF model is far more conservative. It puts future cash flow value at just $0.94 per share, which implies the current $7.44 price sits well above that estimate. Which signal do you trust more: sentiment or cash flows?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Lumen Technologies for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 58 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

The split between a bullish narrative and a cautious DCF view leaves plenty of room for debate, so consider testing the assumptions that matter most to you, then weigh them against the company's 3 important warning signs

Looking for more investment ideas?

If this governance story has you thinking more broadly about your portfolio, do not stop with one stock. Use targeted screens to uncover opportunities that fit your style.

• Zero in on potential value opportunities by scanning 58 high quality undervalued stocks that pair healthier fundamentals with prices that may not fully reflect them yet.
• Strengthen your focus on resilience by filtering for 72 resilient stocks with low risk scores that score well on financial health and business risk factors.
• Broaden your opportunity set by reviewing a screener containing 23 high quality undiscovered gems that the market may not be paying full attention to yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.